Title: Acromegaly: Improving Timely Diagnosis, Assessment, and Treatment

Faculty:
Maria Fleseriu, MD, FACE
Professor of Medicine and Neurological Surgery
Director Pituitary Center
Oregon Health and Science University,
Portland, OR

Lisa B. Nachtigall, MD
Associate Professor of Medicine Harvard Medical School
Clinical Director, Neuroendocrine & Pituitary Tumor Clinical Center
Massachusetts General Hospital
Boston, MA

Date:
May 1, 2023 through May 8, 2024

Target Audience:
Endocrinologists and other health professionals who treat, care, or manage patients with acromegaly, or who wish to improve their knowledge and competence of this rare disorder.

Educational Objectives:

• Identify key clinical findings and presenting symptoms of patients that may be at high risk for acromegaly
• Discuss effective diagnostic strategies that allow for earlier treatment selection while reviewing the consequences of a delayed diagnosis
• Describe the common comorbidities associated with acromegaly and the burden on patient QoL despite endocrine control
• Assess currently approved and emerging treatment options for managing patients with acromegaly

Accreditation and Designation Statements:
EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

EXCEL Continuing Education designates the live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Disclosures:
Dr. Fleseriu has indicated that she is a scientific consultant for Amryt, Ipsen, Pfizer and Recordati Rare Diseases and has received research support at her university from Amryt, Crinetics, Ionis, and Recordati Rare Diseases.

Dr. Nachtigall has indicated that she is an advisor and researcher for Amryt, Recordati Rare Diseases and Chiasma; a consultant for Corcept; and has received grants at her university from Amryt and Recordati Rare Diseases.

EXCEL staff and the peer reviewer have no financial information to disclose.

All relevant financial information has been mitigated.

Instructions for Obtaining Credit:
To be awarded credit, you must view the entire presentation, score 70% or higher on the posttest and then complete the evaluation.

This educational initiative is supported by an educational grant from AMRYT PHARMA.